Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
12/11/2017 12/12/2017 12/13/2017 12/14/2017 12/15/2017 Date
105.15(c) 106.65(c) 106.4(c) 105.1(c) 106.5(c) Last
1 560 433 2 353 821 1 997 481 2 610 049 6 184 479 Volume
+0.43% +1.43% -0.23% -1.22% +1.33% Change
More quotes
Financials (€)
Sales 2017 35 679 M
EBIT 2017 7 597 M
Net income 2017 6 179 M
Debt 2017 8 778 M
Yield 2017 2,46%
Sales 2018 38 379 M
EBIT 2018 8 539 M
Net income 2018 4 927 M
Debt 2018 6 921 M
Yield 2018 2,61%
P/E ratio 2017 14,03
P/E ratio 2018 18,35
EV / Sales2017 2,71x
EV / Sales2018 2,48x
Capitalization 88 070 M
More Financials
Company
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro.The Pharmaceuticals segment engages in... 
Sector
Pharmaceuticals
Calendar
02/28Earnings Release
More about the company
Surperformance© ratings of Bayer
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER
12/14 BAYER : Studies from Bayer Update Current Data on Nerve Tissue Proteins (A tripa..
12/13 BAYER : rivaroxaban submitted to U.S. FDA for approval in patients with coronary..
12/13DJPLANT IMPACT : Needs Extra GBP7 Million Funding by April, Hands up 'For Sale' Si..
12/12 Monsanto offers cash to U.S. farmers who use controversial chemical
12/08 EU regulators to warn Bayer about Monsanto bid
12/08 BAYER : Preventive Maintenance & service solution on existing Bayer/Medrad and A..
12/08 BAYER : J-- Preventive Maintenance & service solution on existing Bayer/Medrad a..
12/08 'Right steps' point to a healthier China
12/07 BAYER : Research Conducted at Bayer Has Provided New Information about Atrial Fi..
12/07 BAYER : Findings from Bayer Has Provided New Data on Liver Cancer (Exposure-resp..
More news
Sector news : Pharmaceuticals - NEC
04:21p TEVA PHARMACEUTICAL INDUSTRIES : Strike over Teva Pharm job cuts briefly shuts d..
12/16 NELSON PELTZ : P&G appoints Peltz to board despite losing proxy battle
12/16 PROCTER & GAMBLE : P&G appoints Peltz to board despite losing proxy battle
12/15 JAZZ PHARMACEUTICALS : Pennsylvania man admits to trading on tips about drug com..
12/15DJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BAYER 
BAYER - 11/20
Comeback of a rising trend ?
BUY
BAYER AG - 2016
Good timing to anticipate the return of volatility
BUY
More Strategies
News from SeekingAlpha
12/15 MY JOURNEY TO FINANCIAL INDEPENDENCE : 86-Stock November Portfolio Update - Buyi..
12/15 Nektar Therapeutics down 1% premarket after Bayer bails on agreement to devel..
12/14 3 THINGS IN BIOTECH YOU SHOULD LEARN : December 14, 2017
12/11 Buy Celgene And Regeneron On The Dips As Insiders Are Buying
12/08 BLOOMBERG : Bayer to face EU objections to Monsanto deal in coming days
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 121 €
Spread / Average Target 14%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER6.02%103 473
JOHNSON & JOHNSON22.95%382 722
PFIZER12.25%221 738
NOVARTIS13.09%221 731
ROCHE HOLDING LTD.3.91%212 270
MERCK AND COMPANY-4.86%153 386